Telesis Biotherapeutics

Telesis Bio is transforming how the world builds biology through synthetic DNA and mRNA synthesis technology. The company's flagship Gibson SOLA platform enables on-demand, high-fidelity DNA and mRNA synthesis directly within customer labs, eliminating outsourcing delays and giving scientists full control over their build timelines, data, and discovery pipelines. Founded in 2013 and led by Dr. Dan Gibson — pioneer of the industry-standard Gibson Assembly method — Telesis Bio has accumulated over 6,000 scientific citations and 300 patents. Researchers in top-tier biopharma and emerging biotech use Telesis Bio's technology to accelerate breakthroughs in vaccine development, precision immunotherapy, antibody engineering, and cell and gene therapy.